Neurocrine Biosciences
NBIX
#1674
Rank
S$16.62 B
Marketcap
S$165.69
Share price
0.15%
Change (1 day)
7.04%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024: S$0.77 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are S$2.68 Billion. In 2024 the company made an earning of S$0.77 Billion, an increase over its 2023 earnings that were of S$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024S$0.77 B96.41%
2023S$0.39 B41.13%
2022S$0.27 B73.74%
2021S$0.16 B-8.82%
2020S$0.17 B77.78%
2019S$99.13 M49.83%
2018S$66.16 M-142.57%
2017-S$0.16 Billion-14.73%
2016-S$0.19 Billion53.15%
2015-S$0.12 Billion46.25%
2014-S$81.38 Million29.66%
2013-S$62.77 Million-3530.8%
2012S$1.82 M-95.73%
2011S$42.85 M
2009-S$60.25 Million-45.38%
2008-S$0.12 Billion-58.87%
2007-S$0.27 Billion87.3%
2006-S$0.15 Billion351.97%
2005-S$31.68 Million-52.09%
2004-S$66.12 Million-10.98%
2003-S$74.28 Million
2001-S$55.45 Million
1999-S$25.01 Million108.32%
1998-S$12.01 Million
1996S$3.66 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$14.97 B 1,932.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.09 B 184.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.43 B 3,758.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$33.02 M-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$52.77 Million-107.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$63.86 M-91.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$6.06 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
S$1.99 B 171.24%๐Ÿ‡ฌ๐Ÿ‡ง UK